KTTA Pasithea Therapeutics Corp.

Fundamentals / CIK 0001841330 / USD
Other share classes on CIK 0001841330: KTTAW

Pasithea Therapeutics Corp. reported $46.49M in total assets and a net loss of $24.83M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KTTA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$2.64M$1.32M$0-$19.14MFY 2021 Revenue: $15KFY 2021 Net Income: -$2.17M2021FY 2022 Revenue: $487KFY 2022 Net Income: -$13.94M2022FY 2023 Net Income: -$15.96M2023FY 2024 Net Income: -$13.90M2024FY 2025 Net Income: -$20.43M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $487K $15K
Cost of Revenue -- -- -- $113K $17K
Gross Profit -- -- -- $373K -$2.2K
Research & Development $7.98M $7.20M $8.10M $2.67M --
Selling, General & Admin -- $7.05M $7.88M $9.92M $4.51M
Operating Income -$20.86M -$14.25M -$15.98M -$12.59M -$4.51M
EBITDA -$20.19M -$13.60M -$15.33M -$12.58M -$4.51M
Interest Income $327K $423K $415K -- --
Interest Expense -- -- -- $102 $508
Income Before Tax -$20.43M -$13.90M -$15.51M -$11.73M -$2.17M
Net Income -$20.43M -$13.90M -$15.96M -$13.94M -$2.17M
Basic EPS -$2.91 -$12.69 -$0.42 -$1.76 -$0.21
Diluted EPS -$2.91 -$12.69 -$0.42 -$1.76 -$0.21
Basic Shares Outstanding 7.0M 1.1M 1.2M 1.3M 10.4M
Diluted Shares Outstanding 7.0M 1.1M 1.2M 1.3M 10.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $4.46M $3.69M $2.94M $2.74M $1.36M $2.15M $1.73M $1.51M
Operating Income -$6.97M -$5.71M -$4.88M -$10.26M -$3.11M -$3.81M -$3.68M -$3.26M
EBITDA -- -- -- -$10.10M -$3.09M -$3.65M -$3.52M -$3.10M
Interest Income $371K $410K $450K $182K $43K $54K $47K $80K
Income Before Tax -$6.58M -$5.27M -$2.87M -$10.11M -$3.04M -$3.72M -$3.56M -$3.18M
Net Income -$6.58M -$5.27M -$2.87M -$10.11M -$3.04M -$3.72M -$3.56M -$3.18M
Basic EPS -$0.20 -$0.16 -$0.12 -- -$0.41 -$0.66 -$1.61 --
Diluted EPS -$0.20 -$0.16 -$0.12 -- -$0.41 -$0.66 -$1.61 --
Basic Shares Outstanding 33.4M 32.1M 24.3M -- 7.4M 5.6M 2.2M --
Diluted Shares Outstanding 33.4M 32.1M 24.3M -- 7.4M 5.6M 2.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $55.16M $6.92M $16.33M $33.09M $52.97M $244K
Cash & Short-Term Investments $55.16M $6.92M $16.33M $33.09M $52.97M $244K
Other Current Assets $388K $143K $105K $263K -- --
Total Current Assets $56.46M $7.37M $16.69M $34.08M $53.30M $248K
Property, Plant & Equipment, Net -- $122K $141K $125K $20K --
Goodwill -- $1.26M $1.26M $1.26M -- --
Intangible Assets $2.90M $7.31M $7.94M $8.57M -- --
Total Non-Current Assets $3.78M $8.70M $9.42M $11.10M $20K $0
Total Assets $60.24M $16.06M $26.12M $45.18M $53.32M $248K
Total Current Liabilities $4.97M $1.12M $2.63M $1.88M $447K $6.6K
Total Non-Current Liabilities $47K $162K $84K $804K $1.45M $0
Total Liabilities $5.02M $1.28M $2.72M $2.68M $1.90M $6.6K
Total Debt (incl. Leases) -- -- $82K $504K -- --
Common Stock $2.3K $139 $104 $130 $18K $15K
Retained Earnings -$70.01M -$49.58M -$35.32M -$19.36M -$2.21M -$41K
Accumulated Other Comp. Income $19K -$7.2K -$4.7K -$661 -$11K --
Total Stockholders' Equity $55.22M $14.78M $23.40M $42.50M $51.42M $241K
Total Equity $55.22M $14.78M $23.40M $42.50M $51.42M $241K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $41.22M $45.66M $50.40M $55.16M $4.12M $7.22M $5.34M $6.92M
Cash & Short-Term Investments $41.22M $45.66M $50.40M $55.16M $4.12M $7.22M $5.34M $6.92M
Other Current Assets $35K $23K $400K $388K $20K $118K $162K $143K
Total Current Assets $43.18M $48.24M $52.73M $56.46M $5.53M $8.64M $6.12M $7.37M
Property, Plant & Equipment, Net -- -- -- -- -- $114K $118K $122K
Goodwill -- -- -- -- $1.26M $1.26M $1.26M $1.26M
Intangible Assets $3.31M $3.47M $3.62M $2.90M $6.84M $7.00M $7.15M $7.31M
Total Non-Current Assets $3.31M $3.47M $3.62M $3.78M $8.10M $8.37M $8.53M $8.70M
Total Assets $46.49M $51.71M $56.35M $60.24M $13.63M $17.01M $14.66M $16.06M
Total Current Liabilities $2.76M $1.84M $1.49M $4.97M $1.38M $1.74M $1.59M $1.12M
Total Non-Current Liabilities $0 $32K $53K $47K $47K $94K $85K $162K
Total Liabilities $2.76M $1.87M $1.54M $5.02M $1.42M $1.83M $1.68M $1.28M
Common Stock $3.3K $3.3K $2.5K $2.3K $743 $743 $270 $139
Retained Earnings -$84.73M -$78.15M -$72.88M -$70.01M -$59.90M -$56.86M -$53.15M -$49.58M
Accumulated Other Comp. Income $48K $9.6K $47K $19K $18K $5.6K -- -$7.2K
Total Stockholders' Equity $43.73M $49.84M $54.80M $55.22M $12.21M $15.18M $12.98M $14.78M
Total Equity $43.73M $49.84M $54.80M $55.22M $12.21M $15.18M $12.98M $14.78M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$20.43M -$13.90M -$15.96M -$13.94M -$2.17M
Depreciation & Amortization $663K $649K $648K $5.1K $1.4K
Stock-Based Compensation $297K $774K $592K $835K $471K
Operating Cash Flow -$15.21M -$13.92M -$12.81M -$14.56M -$3.17M
Capital Expenditure -- -- -$34K -$107K -$22K
Free Cash Flow -- -- -$12.85M -$14.67M -$3.20M
Acquisitions, Net -- -- -- -$2.19M --
Investing Cash Flow $11K -- $75K -$2.06M -$22K
Common Stock Issued $2.08M $4.52M -- -- $1.21M
Share Repurchases -- -- -$3.73M -- --
Financing Cash Flow $63.52M $4.52M -$3.73M -$3.21M $55.93M
Net Change in Cash $48.34M -$9.41M -$16.76M -$19.81M $52.72M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$6.58M -$5.27M -$2.87M -$10.11M -$3.04M -$3.72M -$3.56M -$3.18M
Depreciation & Amortization -- -- -- $158K $24K $161K $162K $162K
Stock-Based Compensation $436K $330K $139K $88K $53K $58K $99K $118K
Operating Cash Flow -$4.48M -$4.71M -$4.79M -$5.40M -$2.89M -$3.87M -$3.06M -$2.44M
Common Stock Issued -- -- -- $68K $0 $358K $1.65M --
Financing Cash Flow $0 $8.5K $750 $56.42M -$116K $5.74M $1.47M --
Net Change in Cash -$4.45M -$4.74M -$4.76M $51.04M -$2.99M $1.88M -$1.58M -$2.44M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- 76.7% -14.7%
Operating Margin -- -- -- -2587.3% -29925.7%
Net Profit Margin -- -- -- -2864.3% -14430.5%
Return on Equity (ROE) -37.0% -94.1% -68.2% -32.8% -4.2%
Return on Assets (ROA) -33.9% -86.6% -61.1% -30.8% -4.1%
Current Ratio 11.35x 6.58x 6.34x 18.15x 119.17x
Quick Ratio 11.09x 6.18x 6.20x 17.62x 118.42x
Debt to Equity -- -- 0.00x 0.01x --
Revenue Growth (YoY) -- -- -- +3130.4% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -56.8% -42.7% -36.0% -37.0% -110.5% -88.7% -104.8% -94.1%
Return on Assets (ROA) -53.4% -41.2% -35.0% -33.9% -99.0% -79.1% -92.8% -86.6%
Current Ratio 15.67x 26.25x 35.40x 11.35x 4.02x 4.97x 3.84x 6.58x
Quick Ratio 14.96x 24.85x 33.84x 11.09x 2.99x 4.15x 3.35x 6.18x
Source: SEC EDGAR CompanyFacts (CIK 0001841330) · from September 30, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal